Prescription Drug Monitoring Act of 2024

This bill requires states receiving federal funding for prescription drug monitoring programs (PDMPs) to implement specific measures. It mandates that doctors and other prescribers check the state PDMP before writing new prescriptions for certain controlled substances (schedules II-IV) and every three months during ongoing treatment. Pharmacies must report each prescription electronically in real-time or within 24 hours. States must also analyze PDMP data publicly, share it with law enforcement and licensing boards when needed, and ensure data can be exchanged between states. The goal is to improve oversight of controlled substance prescribing and dispensing to help prevent misuse.